ISR Immune System Regulation

Less than 1K followers

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Privacy preferences

ISR Immune System Regulation

ISR Immune System Regulation

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR, Audiocast with teleconference, Half-year report 2022

ISR: SARS-CoV-2 vaccine study approved by Bangladesh BMRC

Join Inderes community

Inderes account

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

Delegation from Bangladesh visits ISR for study preparation

Redeye: Redeye Initiates Coverage of ISR Holding

ISR, Audiocast with teleconference, Year-end Report, 2021

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR, Audiocast with teleconference, Half-year report 2022

ISR: SARS-CoV-2 vaccine study approved by Bangladesh BMRC

Join Inderes community

Inderes account

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

Delegation from Bangladesh visits ISR for study preparation

Redeye: Redeye Initiates Coverage of ISR Holding

ISR, Audiocast with teleconference, Year-end Report, 2021